Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 48 non-cytoplasmic 49 69 transmembrane 70 80 cytoplasmic 81 100 transmembrane 101 105 non-cytoplasmic 106 127 transmembrane 128 138 cytoplasmic 139 161 transmembrane 162 172 non-cytoplasmic 173 195 transmembrane 196 240 cytoplasmic 241 262 transmembrane 263 273 non-cytoplasmic 274 294 transmembrane 295 305 cytoplasmic 306 325 transmembrane 326 330 non-cytoplasmic 331 351 transmembrane 352 359 cytoplasmic 360 384 transmembrane 385 397 non-cytoplasmic 398 419 transmembrane 420 440 cytoplasmic
Input: >Pf1N1B4_4622 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_4622 MSQELRLIRRITLKLIPFLILLYLIAYVDRSAVGFAKLHMGADIGLGDAAYGLGAGLFFI GYFLLEIPSNLMLDRFGARRWFARIMVTWGAITIGMAFVQGPNSFYVMRFLLGAAEAGFF PGVLYYITQWFPIRHRGKILGLFILSQPIAMMITGPVSGGLLGMDGIFGLHGWQWLFIVI GMPAILLTWPVLRYLPDGPQQVKWMDQSEKDWLTGELKKDLEVYGQTRHGNPLHALKDKR VLLLALFYLPVTLSIYGLGLWLPTLIKQFGGTDLVTGFVSSVPYIFGIIGLLIIPRSSDR LNDRYGHLAVLYVLGAIGLFLSAWLTVPVLQLAALCLVAFALFSCTAVFWTLPGRFFAGA SAAAGIALINSVGNLGGYIGPFVIGALKEYTGNLASGLYFLSCVMVFGLVLTGVVYRLLE RKHVLPADQFAASARGATRT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server